Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes
Authors:
- Tania Quesada-LópezTQTania Quesada-López
- Marta GiraltMarta Giralt
Open Access
- 9 September 2022
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 308, 120948
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor DolutegravirClinical Pharmacokinetics, 2013
- Effects of Rilpivirine on Human Adipocyte Differentiation, Gene Expression, and Release of Adipokines and CytokinesAntimicrobial Agents and Chemotherapy, 2012
- Effects of nevirapine and efavirenz on human adipocyte differentiation, gene expression, and release of adipokines and cytokinesAntiviral Research, 2011
- Adipose tissue biology and HIV-infectionBest Practice & Research Clinical Endocrinology & Metabolism, 2011
- HIV-associated lipodystrophy: from fat injury to premature agingTrends in Molecular Medicine, 2010
- The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3T3-L1 adipocytes: Role of the NF-κB pathwayInternational Journal of Molecular Medicine, 2009
- Human SGBS Cells – a Unique Tool for Studies of Human Fat Cell BiologyObesity Facts, 2008
- HIV Protease Inhibitor‐Specific Alterations in Human Adipocyte Differentiation and MetabolismObesity, 2006
- The Effect of the HIV Protease Inhibitor Ritonavir on Proliferation, Differentiation, Lipogenesis, Gene Expression and Apoptosis of Human Preadipocytes and AdipocytesHormone and Metabolic Research, 2005
- Characterization of a human preadipocyte cell strain with high capacity for adipose differentiationInternational Journal of Obesity, 2001